Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 42nd Annual Growth...
May 16, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® CTD and AVISE® Lupus are a contracted covered...
May 11, 2022 16:06 ET | Source: Exagen Inc.

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Medicare Administrative Contractor (MAC) Noridian has...
May 11, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports First Quarter 2022 Results

SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2022. ...
May 01, 2022 12:00 ET | Source: Exagen Inc.

Exagen Announces Five-Week Campaign for Lupus Awareness Month

SAN DIEGO, May 01, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a...
April 25, 2022 16:05 ET | Source: Exagen Inc.

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

SAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2022,...
April 20, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

SAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in Investor Summit Group’s Q2...
March 30, 2022 08:25 ET | Source: Exagen Inc.

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests have entered into an in-network...
March 22, 2022 16:06 ET | Source: Exagen Inc.

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests will soon surpass 90 million lives as...
March 22, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...